Systane Max vs. Systane Ultra: Different Formulations
No, Systane Max and Systane Ultra are not the same products—they have distinctly different formulations designed for different aspects of dry eye disease. Systane Max (propylene glycol-hydroxypropyl guar nano-emulsion) is a lipid-based formulation, while Systane Ultra (polyethylene glycol/propylene glycol with hydroxypropyl guar) is a non-lipid-based artificial tear.
Key Formulation Differences
Systane Ultra contains:
- Polyethylene glycol (PEG) 0.4% and propylene glycol (PG) 0.3% as active demulcents
- Hydroxypropyl guar (HP-guar) gelling technology
- Non-lipid formulation targeting aqueous and mucin layer deficiencies 1, 2
Systane Max (marketed as Systane Complete) contains:
- Propylene glycol 0.6% as the demulcent
- Hydroxypropyl guar with nanoemulsion technology
- Dimyristoyl phosphatidyl glycerol (an anionic phospholipid) for lipid layer replenishment
- Lipid-based formulation targeting evaporative dry eye 3
Clinical Performance Differences
The lipid-based formulation (Systane Max/Complete) demonstrates superior performance in specific parameters:
- Lipid layer quality: Only the lipid-containing formulation significantly improved lipid layer grade (p=0.003), while the non-lipid formulation did not 4
- Symptom relief: After adverse environmental exposure, the lipid-containing drops provided more favorable symptom scores and tear film stability (all p<0.05) 4
- Evaporative dry eye: The lipid-based formulation specifically addresses tear evaporation by stabilizing the lipid layer 3
Both formulations share the hydroxypropyl guar technology that forms a protective gel matrix on the ocular surface when exposed to tear film pH, prolonging retention time 3, 2.
Clinical Decision-Making
Choose Systane Max (Complete) when:
- Patient has evaporative dry eye or meibomian gland dysfunction
- Lipid layer deficiency is present
- Patient needs protection in adverse environmental conditions
- Mixed dry eye with lipid component
Choose Systane Ultra when:
- Patient has primarily aqueous-deficient dry eye
- Mucin layer deficiency is present
- Patient prefers a non-lipid formulation
- Cost is a consideration (typically less expensive)
Important Caveats
Both products are effective and safe for dry eye management 5. The 2024 AAO Dry Eye Preferred Practice Pattern notes that "most artificial tears may have comparable efficacies" but emphasizes matching formulation to dry eye subtype 5.
When using either product more than 4 times daily, preservative-free versions are recommended to avoid toxicity to the ocular surface 5.
The nanoemulsion technology in Systane Max provides a depot delivery system for the phospholipid component, enhancing ocular surface coverage beyond what non-lipid formulations can achieve 3.